Clinical Trials Browser

Phase 1/2 × INDUSTRY × vadimezan × Clear all

NCT00832494 2009-01-30

Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung